← 產業報告目錄
AI-Enabled Drug Discovery and Clinical Trials Market Size, Share & Trends Analysis Report By Component Scope (Solutions, Services), By Application, By Therapeutic Application, By End-Users, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-01-31頁數 190報告編號 INSIGHTACE-83fe2c4608
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 883.9 Million, the global AI-Enabled Drug Discovery and Clinical Trials Market is projected to accelerate to USD 9321.5 Million by 2034, demonstrating a CAGR of 26.7% during the 2025–2034 forecast window.
AI-Enabled Drug Discovery and Clinical Trials encompasses key industry insights & findings from the report:
Technology advancements enhance the ability to analyze drug discovery processes, which is driving the ai-enabled drug discovery and clinical trials m. The sector has gained traction as organizations seek innovative approaches to address evolving technology and communications challenges.
Market momentum is underpinned by rising need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-Enabled Drug Discovery and Clinical Trials Market Snapshot
Chapter 4. Global AI-Enabled Drug Discovery and Clinical Trials Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Industry Analysis – Porter's Five Forces Analysis
4.6. Competitive Landscape
4.7. Technology Advancement in Global AI-Enabled Drug Discovery and Clinical Trials Market
Chapter 5. Market Segmentation 1: Component Estimates & Trend Analysis
5.1. Component Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Component:
5.2.1. Solutions
5.2.2. Services
Chapter 6. Market Segmentation 2: Application & Trend Analysis
6.1. Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Data Aggregation and Analysis
6.2.2. Clinical Trials
6.2.3. Drug Design
6.2.4. Drug Characterization
6.2.5. Biomarker Research
Chapter 7. Market Segmentation 3: Therapeutic Application Estimates & Trend Analysis
7.1. Therapeutic Application & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapeutic Application:
7.2.1. Oncology
7.2.2. Cardiovascular Diseases
7.2.3. Nervous System Diseases
7.2.4. Respiratory Disorder
7.2.5. Metabolic Diseases
7.2.6. Immunologic Diseases
7.2.7. Infectious Diseases
Chapter 8. Global AI-Enabled Drug Discovery and Clinical Trials Market Segmentation 4: End-Users Estimates & Trend Analysis
8.1. End-Users Analysis & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-Users:
8.2.1. Biopharmaceutical Industry
8.2.2. Contract Research Organizations (CROs)
8.2.3. Academic Institutes and Research Centers
Chapter 9. Global AI-Enabled Drug Discovery and Clinical Trials Market Segmentation 3: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Component, 2021-2034
9.1.2. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.1.3. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.1.4. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by End-Users, 2021-2034
9.1.5. North America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.1.5.1. U.S.
9.1.5.2. Canada
9.2. Europe
9.2.1. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by Component, 2021-2034
9.2.2. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.2.3. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.2.4. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by End-Users, 2021-2034
9.2.5. Europe Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by country, 2021-2034
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by Component, 2021-2034
9.3.2. Asia Pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.3.3. Asia pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.3.4. Asia Pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by End-Users, 2021-2034
9.3.5. Asia Pacific Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by country, 2021-2034
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by Component, 2021-2034
9.4.2. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.4.3. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.4.4. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by End-Users, 2021-2034
9.4.5. Latin America Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. MEA
9.5.1. MEA revenue Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by Component, (US$ Million) 2021-2034
9.5.2. MEA Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Application, 2021-2034
9.5.3. MEA Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) estimates and forecasts by Therapeutic Application, 2021-2034
9.5.4. MEA revenue Global AI-Enabled Drug Discovery and Clinical Trials Market revenue (US$ Million) by country, (US$ Million) 2021-2034
9.5.4.1. South Africa
9.5.4.2. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Accutar Biotechnology Inc.
10.2.2. AiCure
10.2.3. Ardigen
10.2.4. Atomwise Inc.
10.2.5. Benevolent AI
10.2.6. Berg
10.2.7. Berkeley Lights
10.2.8. BioAge Labs
10.2.9. Biovista
10.2.10. C4X Discovery Holdings Plc
10.2.11. Clinithink Ltd
10.2.12. Cloud Pharmaceuticals
10.2.13. Cyclica Inc.
10.2.14. CytoReason
10.2.15. Concerto Health AI.
10.2.16. Deep Genomics Inc.
10.2.17. DeepThink Health Inc.
10.2.18. Envisagenics, Inc.
10.2.19. Exscientia Limited
10.2.20. e-therapeutics plc
10.2.21. GNS Healthcare
10.2.22. Insilico Medicine
10.2.23. Lantern Pharma Inc.
10.2.24. Medable, Inc.
10.2.25. Mind the Byte
10.2.26. NuMedii, Inc
10.2.27. Nuritas, Ltd.
10.2.28. Owkin, Inc.
10.2.29. Recursion Pharmaceuticals, Inc.
10.2.30. Schrödinger, LLC
10.2.31. Symphony Innovation, LLC
10.2.32. TARA Biosystems, Inc.
10.2.33. twoXAR, Incorporated
10.2.34. Verge Analytics, Inc.
10.2.35. Winterlight Labs Inc.
10.2.36. WuXi Nextcode Genomics
10.2.37. XtalPi Inc.
10.2.38. Other Prominent Player
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們